Highlander Capital Management, LLC Sage Therapeutics, Inc. Transaction History

Highlander Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$54.88 - $79.29 $27,440 - $39,645	-500 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$70.65 - $96.76 $35,325 - $48,380	500 New	500 $37,000
Q1 2020 May 27, 2020	SELL	$26.15 - $77.24 $13,075 - $38,620	-500 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$60.18 - $154.77 $30,090 - $77,385	500 New	500 $36,000
Q3 2019 Nov 14, 2019	SELL	$140.29 - $189.96 $42,087 - $56,988	-300 Closed	0 $0

Q1 2019 May 15, 2019	BUY	$89.33 - $163.65 $26,799 - $49,095	300 New	300 $48,000

220

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $730M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Highlander Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Highlander Capital Management, LLC with notifications on news.